In medical trials, the incidence of opportunistic infections was very similar in patients employing immunosuppressive regimens with or without Simulect. In the pooled Assessment of two 5-calendar year extension research, no differences were found in the incidence of malignancies and LPDs involving immunosuppressive regimens with or without blend of